Logo image of PGNY

PROGYNY INC (PGNY) Stock Price, Quote, News and Overview

NASDAQ:PGNY - Nasdaq - US74340E1038 - Common Stock - Currency: USD

23.59  +0.64 (+2.79%)

After market: 23.59 0 (0%)

PGNY Quote, Performance and Key Statistics

PROGYNY INC

NASDAQ:PGNY (1/28/2025, 5:19:57 PM)

After market: 23.59 0 (0%)

23.59

+0.64 (+2.79%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryManaged Health Care
Statistics
52 Week High42.08
52 Week Low13.39
Market Cap2.01B
Shares85.15M
Float71.91M
Yearly DividendN/A
Dividend YieldN/A
PE40.67
Fwd PE38.18
Earnings (Next)N/A N/A
IPO10-25 2019-10-25


PGNY short term performance overview.The bars show the price performance of PGNY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60

PGNY long term performance overview.The bars show the price performance of PGNY in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of PGNY is 23.59 USD. In the past month the price increased by 60.37%. In the past year, price decreased by -39.65%.

PROGYNY INC / PGNY Daily stock chart

PGNY Latest News, Press Releases and Analysis

News Image
9 hours ago - Progyny, Inc.

Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump

Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning

News Image
9 hours ago - Progyny, Inc.

Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump

Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning...

News Image
6 days ago - The Motley Fool

These 3 Stocks Are Down to Start 2025. What's Going On?

Sonos, Moderna, and Shake Shack are all staring at some near-term headwinds – can they work through them?

News Image
12 days ago - Progyny, Inc.

Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors

NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women’s health benefits...

PGNY Competitors/Peers

The largest stocks on the US markets in the "Managed Health Care" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
UNH UNITEDHEALTH GROUP INC 19.43 499.23B
ELV ELEVANCE HEALTH INC 12.3 94.02B
HUM HUMANA INC 16.62 36.50B
CNC CENTENE CORP 9.59 32.68B
MOH MOLINA HEALTHCARE INC 13.99 17.58B
HQY HEALTHEQUITY INC 35.08 9.33B
ALHC ALIGNMENT HEALTHCARE INC N/A 2.92B
CLOV CLOVER HEALTH INVESTMENTS CO N/A 2.30B
NEUE NEUEHEALTH INC 5.57 60.93M

About PGNY

Company Profile

PGNY logo image Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 563 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Company Info

PROGYNY INC

1359 Broadway

New York City NEW YORK 10018 US

CEO: David Schlanger

Employees: 563

Company Website: https://www.progyny.com/

Investor Relations: https://investors.progyny.com/

Phone: 12128883124

PGNY FAQ

What is the stock price of PGNY?

The current stock price of PGNY is 23.59 USD.


What is the symbol for PROGYNY INC stock?

The exchange symbol of PROGYNY INC is PGNY and it is listed on the Nasdaq exchange.


On which exchange is PGNY stock listed?

PGNY stock is listed on the Nasdaq exchange.


Is PGNY a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PGNY, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PGNY.


Does PGNY stock pay dividends?

PGNY does not pay a dividend.


What is the Price/Earnings (PE) ratio of PGNY?

The PE ratio for PGNY is 40.67. This is based on the reported non-GAAP earnings per share of 0.58 and the current share price of 23.59 USD.


What is the Short Interest ratio of PGNY stock?

The outstanding short interest for PGNY is 16.18% of its float.


PGNY Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to PGNY. When comparing the yearly performance of all stocks, PGNY turns out to be only a medium performer in the overall market: it outperformed 63.86% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PGNY Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to PGNY. PGNY gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PGNY Financial Highlights

Over the last trailing twelve months PGNY reported a non-GAAP Earnings per Share(EPS) of 0.58. The EPS increased by 11.54% compared to the year before.


Industry RankSector Rank
PM (TTM) 5.03%
ROA 8.68%
ROE 13.17%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-31.25%
Sales Q2Q%2.04%
EPS 1Y (TTM)11.54%
Revenue 1Y (TTM)10.24%

PGNY Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 76% to PGNY. The Buy consensus is the average rating of analysts ratings from 16 analysts.

For the next year, analysts expect an EPS growth of -9.78% and a revenue growth 4.76% for PGNY


Ownership
Inst Owners99.26%
Ins Owners6.57%
Short Float %16.18%
Short Ratio6.6
Analysts
Analysts76.25
Price Target19.23 (-18.48%)
EPS Next Y-9.78%
Revenue Next Year4.76%